Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  SI-BONE, Inc.    SIBN

SI-BONE, INC.

(SIBN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Si-Bone: 2Q Earnings Snapshot

share with twitter share with LinkedIn share with facebook
08/03/2020 | 06:02pm EDT

SANTA CLARA, Calif. (AP) _ Si-Bone Inc. (SIBN) on Monday reported a loss of $12.5 million in its second quarter.

On a per-share basis, the Santa Clara, California-based company said it had a loss of 44 cents.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 64 cents per share.

The medical device maker posted revenue of $14 million in the period.

Si-Bone shares have declined 19% since the beginning of the year. In the final minutes of trading on Monday, shares hit $17.48, a fall of 2.5% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SIBN at https://www.zacks.com/ap/SIBN

© 2020 The Canadian Press. All rights reserved., source Canadian Press DataFile


share with twitter share with LinkedIn share with facebook
All news about SI-BONE, INC.
10/19SI BONE : To Report Third Quarter 2020 Financial Results on November 2, 2020
AQ
10/19SI-BONE To Report Third Quarter 2020 Financial Results on November 2, 2020
GL
10/16SI-BONE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
10/15SI BONE : NASS virtual Conference Surgeon Panel Presentation
PU
10/14SI BONE : Announces Pricing of Public Offering of Common Stock
AQ
10/14SI-BONE Announces Pricing of Public Offering of Common Stock
GL
10/14SI BONE : Announces Launch of Public Offering of Common Stock
AQ
10/14SI-BONE Announces Launch of Public Offering of Common Stock
GL
10/08SI-BONE, INC. : Results of Operations and Financial Condition, Financial Stateme..
AQ
10/08SI BONE : Reports Preliminary Unaudited Revenue for the Third Quarter 2020 and P..
AQ
More news
Financials (USD)
Sales 2020 69,0 M - -
Net income 2020 -45,3 M - -
Net cash 2020 99,9 M - -
P/E ratio 2020 -14,1x
Yield 2020 -
Capitalization 658 M 658 M -
EV / Sales 2020 8,08x
EV / Sales 2021 6,15x
Nbr of Employees 262
Free-Float 87,6%
Chart SI-BONE, INC.
Duration : Period :
SI-BONE, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SI-BONE, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Average target price 27,50 $
Last Close Price 22,80 $
Spread / Highest target 31,6%
Spread / Average Target 20,6%
Spread / Lowest Target 9,65%
EPS Revisions
Managers
NameTitle
Jeffrey W. Dunn Chairman, President & Chief Executive Officer
Laura A. Francis Chief Operating & Financial Officer
Scott A. Yerby Chief Technology Officer
W. Carlton Reckling Chief Medical Officer & VP-Medical Affairs
Gregory K. Hinckley Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
SI-BONE, INC.6.88%663
NOVOCURE LIMITED56.57%13 378
MASIMO CORPORATION49.15%12 953
ASAHI INTECC CO., LTD.6.09%8 451
GETINGE AB8.48%5 836
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.60.58%4 988